miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs
- PMID: 25236186
- PMCID: PMC4192292
- DOI: 10.1186/s12967-014-0234-x
miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs
Abstract
Background: Recently, miR-10b is identified as a miRNA highly expressed in many human cancers, promoting cell migration and invasion. However, the specific function of miR-10b in hepatocellular carcinoma (HCC) is unclear at this point.
Methods: The miR-10b expression levels in 60 paired different TNM Stage HCC tumor tissues compared with adjacent non-tumor (ANT) tissues, normal tissue control (8 benign tumor and 7 normal liver tissues), 3 normal liver and 7 HCC cell lines were measured by real-time quantitative RT-PCR and to evaluate their association with HCC clinicopathologic features. Invasion assay, MTT proliferation assay and wound-healing assay were performed to test the invasion and proliferation of HCC cell after transfection. The effect of miR-10b on HCC in vivo was validated by murine xenograft model.
Results: We found that miR-10b expression was increased in human HCC tissues and cell lines compared with normal control, respectively. The expression of miR-10b was correlated with HCC metastatic ability. Overexpression of miR-10b in MHCC-97L cells increased cell motility and invasiveness, whereas inhibition of miR-10b in MHCC-97H cells reduced cell motility and invasiveness in vitro and in vivo. We also showed that HOXD10 was negatively regulated by miR-10b at the posttranscriptional level, via a specific target site within the 3'UTR by luciferase reporter assay. Furthermore, we found that miR-10b induced HCC cell invasion and migration by modulating the HOXD10 target gene RhoC, uPAR, MMP-2 and MMP-9 expression.
Conclusions: Our results suggested that miR-10b was overexpressed in HCC and promoted HCC cell migration and invasion through the HOXD10/ RhoC/ uPAR/ MMPs pathway which may provide a novel bio-target for HCC therapy.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4192292/bin/12967_2014_234_Fig1_HTML.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4192292/bin/12967_2014_234_Fig2_HTML.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4192292/bin/12967_2014_234_Fig3_HTML.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4192292/bin/12967_2014_234_Fig4_HTML.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4192292/bin/12967_2014_234_Fig5_HTML.gif)
Similar articles
-
Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.Theranostics. 2019 Mar 16;9(7):1965-1979. doi: 10.7150/thno.30958. eCollection 2019. Theranostics. 2019. PMID: 31037150 Free PMC article.
-
TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.J Exp Clin Cancer Res. 2018 Jun 13;37(1):116. doi: 10.1186/s13046-018-0780-9. J Exp Clin Cancer Res. 2018. PMID: 29898761 Free PMC article.
-
CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.J Exp Clin Cancer Res. 2018 Mar 5;37(1):46. doi: 10.1186/s13046-018-0699-1. J Exp Clin Cancer Res. 2018. PMID: 29506532 Free PMC article.
-
miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).BMC Cancer. 2016 Oct 18;16(1):806. doi: 10.1186/s12885-016-2801-4. BMC Cancer. 2016. PMID: 27756250 Free PMC article.
-
[Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Aug;32(8):1083-7. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016. PMID: 27412940 Chinese.
Cited by
-
In Silico Analysis of MicroRNA Expression Data in Liver Cancer.Cancer Inform. 2023 May 10;22:11769351231171743. doi: 10.1177/11769351231171743. eCollection 2023. Cancer Inform. 2023. PMID: 37200943 Free PMC article.
-
An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis.Int J Mol Sci. 2023 Apr 14;24(8):7268. doi: 10.3390/ijms24087268. Int J Mol Sci. 2023. PMID: 37108432 Free PMC article. Review.
-
Expression of miR-221 and miR-18a in patients with hepatocellular carcinoma and its clinical significance.Korean J Clin Oncol. 2022 Jun;18(1):17-26. doi: 10.14216/kjco.22003. Epub 2022 Jun 30. Korean J Clin Oncol. 2022. PMID: 36945332 Free PMC article.
-
RHO GTPase family in hepatocellular carcinoma.Exp Hematol Oncol. 2022 Nov 8;11(1):91. doi: 10.1186/s40164-022-00344-4. Exp Hematol Oncol. 2022. PMID: 36348464 Free PMC article. Review.
-
The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC.Int J Mol Sci. 2022 Oct 15;23(20):12370. doi: 10.3390/ijms232012370. Int J Mol Sci. 2022. PMID: 36293225 Free PMC article. Review.
References
-
- Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, Gimotty PA, Katsaros D, Coukos G, Zhang L, Puré E, Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol. 2008;10(2):202–210. doi: 10.1038/ncb1681. - DOI - PubMed
-
- Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297(17):1901–1908. doi: 10.1001/jama.297.17.1901. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous